PVLA Competitors & Alternatives
Compare Palvella Therapeutics, Inc with similar stocks in the same industry
Biotechnology
PVLA
Main Stock$150.13
Tradestie Score
54
Market Cap
$699.30M
Analyst Upside
+53.6%
Top Competitors
233 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
IRON
Disc Medicine, Inc. Common Stock
|
$70.06
|
$2.33B | - | 53 | Compare |
|
AGIO
Agios Pharmaceuticals, Inc.
|
$33.60
|
$2.33B | - | 47 | Compare |
|
GLPG
Galapagos NV
|
$27.73
|
$2.31B | 5.1 | 46 | Compare |
|
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
|
$3.20
|
$2.23B | - | 44 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$24.20
|
$2.22B | - | 55 | Compare |
|
TVTX
Travere Therapeutics, Inc. Common Stock
|
$66.17
|
$2.21B | - | 48 | Compare |
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$21.09
|
$2.18B | - | 45 | Compare |
|
MESO
Mesoblast Limited American Depositary Shares
|
$15.48
|
$2.08B | - | 47 | Compare |
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$20.45
|
$2.02B | - | 34 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$11.74
|
$2.01B | - | 32 | Compare |
More PVLA Analysis
Data updated: Sep 12, 2026 | Industry: Biotechnology (SIC 2834)
233 stocks in this industry